the company has successfully initiated a strong biomedical research program for the scientific investigation of our lead compound to demonstrate the anti-viral and anti-oncogenic properties based on multiple signaling pathways of cannabinoid therapeutics. In doing so we have initiated the preclinical
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.